Netols Asset Management’s CONMED CNMD Stock Holding History

Netols Asset Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$6.65M	Sell	149,716 -13,213	-8%	-$568K	1.5%	29
2016 Q4	$7.2M	Buy	162,929 +16,951	+12%	+$720K	1.48%	35
2016 Q3	$5.85M	Sell	145,978 -3,181	-2%	-$135K	1.3%	47
2016 Q2	$7.12M	Buy	149,159 +4,736	+3%	+$201K	1.61%	21
2016 Q1	$6.06M	Sell	144,423 -3,495	-2%	-$137K	1.35%	39
2015 Q4	$6.52M	Buy	147,918 +720	+0.5%	+$31.2K	1.44%	37
2015 Q3	$7.03M	Sell	147,198 -3,099	-2%	-$170K	1.59%	25
2015 Q2	$8.76M	Sell	150,297 -2,569	-2%	-$139K	1.73%	19
2015 Q1	$7.72M	Buy	+152,866	New	+$7.49M	1.5%	29

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Netols Asset Management's CNMD Position: Q1 2017 in Review

Netols Asset Management reduced its CONMED (CNMD) stake by 8.1% in Q1 2017, selling an estimated $568K and leaving 149,716 shares worth $6.65M. The position accounts for 1.5% of the portfolio, ranked #29.

Netols Asset Management first reported a position in CNMD in Q1 2015 and has held it in 9 quarters since. The position peaked at $8.76M in Q2 2015. 142 funds tracked by Wall St. Rank hold CNMD as of Q1 2017.

Netols Asset Management held 149,716 shares of CONMED worth $6.65M as of Q1 2017.
Netols Asset Management sold 13,213 CONMED shares in Q1 2017, an estimated $568K.
CONMED made up 1.5% of Netols Asset Management's portfolio in Q1 2017, its #29 holding.
Netols Asset Management first reported a position in CONMED in Q1 2015 and has held it in 9 quarters since.
Netols Asset Management's CONMED position peaked at $8.76M in Q2 2015.
142 funds tracked by Wall St. Rank held CONMED as of Q1 2017.

Based on Netols Asset Management's 13F filing for Q1 2017, filed 10 May 2017.